|Outsourcing Outlook Eric LangerCMOs Continue to Improve Overall Biomanufacturing Performance|
|Regulatory Watch Jill Wechsler FDA Overhauls Inspection Operations|
|EU Regulatory Watch Sean Milmo EU's New Telematics Strategy for the Regulation of Medicines|
The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.
Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.
New instrumentation at the SGS Mississauga, Canada facility advances testing capabilities for packaging and container testing.